SCHEMBL23701694

SCHEMBL23701694

CCN=c1cc2oc3cc(NCC)c(Cl)cc3nc-2cc1Cl

nearest known ligand 0.33

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 6/20 0.33
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
STAT1 P42224 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 1/20 0.31
GSK3B P49841 1/20 0.30
MAP4K2 Q12851 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21678118 1.00 PGK1 (0.33) PGK1NPC1MAPTSTAT1RAB9A
SCHEMBL21678084 0.91 PGK1 (0.32) PGK1NPC1MAPTSTAT1RAB9A
SCHEMBL23701687 0.91 PGK1 (0.32) PGK1NPC1MAPTSTAT1RAB9A
SCHEMBL23921362 0.88 PGK1 (0.30) PGK1
SCHEMBL3676503 0.80 NPC1 (0.32) NPC1MAPTSTAT1RAB9ASMN1; SMN2
SCHEMBL13428276 0.80 NPC1 (0.32) NPC1MAPTSTAT1RAB9ASMN1; SMN2
SCHEMBL14607913 0.80 NPC1 (0.32) NPC1MAPTSTAT1RAB9ASMN1; SMN2
SCHEMBL23701705 0.79 NPC1 (0.32) NPC1MAPTSTAT1RAB9ASMN1; SMN2
SCHEMBL21710811 0.79 NPC1 (0.32) NPC1MAPTSTAT1RAB9ASMN1; SMN2
SCHEMBL21678192 0.77 NPC1 (0.31) NPC1MAPTSTAT1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492359-B2 Near-infrared nerve-sparing fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2022-11-08 US disclosed
US-20210317137-A1 NEAR-INFRARED NERVE-SPARING FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-10-14 US disclosed
US-20210236657-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11492359-B2 Near-infrared nerve-sparing fluorophores NTRK1, PMP22, GAP43 PGK1 2701/4885NPC1 3548/4885MAPT 636/4885
US-20210236657-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION PFAS, NPFFR2, NPFFR1 PGK1 2401/4885NPC1 1620/4885MAPT 1093/4885
US-20210317137-A1 NEAR-INFRARED NERVE-SPARING FLUOROPHORES NTRK1, NGF, SMN1; SMN2 PGK1 3851/4885NPC1 2076/4885MAPT 803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.